Help Support Development of FDA's Office of Regulatory Affairs Strategic Plan

Submit your comments and feedback by taking the FDA Office of Regulatory Affairs Strategic Plan survey today.

The U.S. Food & Drug Administration Office of Regulatory Affairs (ORA) will be developing a comprehensive 10-year strategic plan that will identify ORA’s goals and objectives based on their core mission and priorities. It will be drafted by the Strategic Plan Development Workgroup, led by ORA’s Office of Strategic Planning and Operational Policy.   

FDA is currently in the information gathering phase and is seeking feedback and comments from internal and external stakeholders. If you are interested in participating in this collaborative activity, submit your comments by taking the ORA Strategic Plan Development Survey.



Release Date: 
Thursday, February 27, 2020